Enavate Sciences: Funding, Team & Investors | Startup Intros

Loading organizations...

Enavate Sciences: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 12, 2026	AirNexis Therapeutics	$200.0M Series A	Anna Chen	Longitude Capital, Evan Caplan, Jill Carroll
Nov 1, 2025	Braveheart Bio	$190.0M Series A	—	Forbion, RA Capital, Andreessen Horowitz, Frazier Life Sciences, OrbiMed
Jan 1, 2025	Normunity	$75.0M Series B	Enavate Sciences, Samsara BioCapital	Aisling Capital, Avoro Ventures, Broadview Ventures, Canaan Partners, Hbm Partners, Polaris Partners, SR One, Taiho Ventures
May 1, 2024	Zenas BioPharma	$200.0M Series C	SR One Capital Management, Tim Xiao, NEA, Norwest Venture Partners	Vivo Capital, ArrowMark Partners, Fairmount, Hermes GPE, Longitude Capital, Pivotal bioVenture Partners, Quan Capital, Rock Springs Capital, Superstring Capital, Wellington Management
Mar 1, 2024	Sionna Therapeutics	$180.0M Series C	Edd Fleming	Atlas Venture, OrbiMed, Third Rock Ventures, Cystic Fibrosis Foundation, Perceptive Advisors, Q Healthcare Holdings, RA Capital Management, Michael Cloonan, TPG, T. Rowe Price Associates, Viking Global Investors
Nov 7, 2023	OrsoBio	$60.0M Series A	Enavate Sciences, Marc Galletti	—
Jun 8, 2023	Upstream Bio	$200.0M Series B	Edd Fleming, Alex Rosen	Access Biotechnology, Altshuler Shaham, Bain Capital Life Sciences, Decheng Capital, HBM Healthcare Investments, Omega Funds, OrbiMed, Samsara BioCapital, TCGX, Wellington Management
Nov 1, 2022	Zenas BioPharma	$120.0M Series B	James Boylan	venBio, Vivo Capital, Agent Capital, Fairmount, Patrick Enright, Perceptive Advisors, Pivotal bioVenture Partners, Quant Venture Fund, Rock Springs Capital, Superstring Capital, Tellus BioVentures, Wellington Management, Xencor
Jul 21, 2022	Camp4	$100.0M Series B	James Boylan	5AM Ventures, Andreessen Horowitz, Gaingels, Northpond Ventures, Polaris Partners, The Kraft Group
Jul 1, 2022	CAMP4 Therapeutics	$100.0M Series B	James Boylan	2xN, 5AM Ventures, Aisling Capital, Andreessen Horowitz, Angel investor, Catalio Capital, Haun Ventures, Highbury Group, Northpond Ventures, OrbiMed, Ulu Ventures, What If Ventures, WndrCo LLC, Andreessen Horowitz, Gaingels, Polaris Partners, The Kraft Group
Jun 22, 2022	Alladapt Immunotherapeutics	$119.0M Other Equity	Jim Momtazee	AllerFund, Sophie P. Kornowski, Pharm. D, MBA, Novartis, Heath Lukatch, George Montgomery